Symbiosis Pharmaceutical Services Wins 2025 King’s Award for Enterprise in International Trade

Symbiosis Pharmaceutical Services (Symbiosis), a global biopharmaceutical Contract Manufacturing Organisation (CMO) specialising in the sterile fill fi...

May 07, 2025 | Wednesday | News
“Too Quiet to Fund?” Jude Research Reveals Bladder Cancer Is One of the UK's Most Underfunded Major Cancers

  To mark Bladder Cancer Awareness Month this May, bladder health brand Jude has conducted new research into how much charitable funding is allocat...

May 06, 2025 | Tuesday | Reports
EU Recommends Approval of Fixed-Duration Calquence Regimen for Untreated Chronic Lymphocytic Leukaemia

A fixed-duration regimen of AstraZeneca’s Calquence (acalabrutinib) in combination with venetoclax, with or without obinutuzumab, has ...

May 01, 2025 | Thursday | News
Stablepharma Doses First Participant in Phase 1 Trial of Fridge-Free Tetanus and Diphtheria Vaccine, SPVX02

 Following MHRA approval, Stablepharma Ltd has commenced a Phase 1 clinical trial with its lead candidate, fridge-free tetanus and diphtheri...

April 29, 2025 | Tuesday | News
CN Bio and Pharmaron Partner to Advance Organ-on-a-Chip Integration in Drug R&D

CN Bio, a leading provider of Organ-on-a-chip systems and solutions that accelerate drug discovery and development workflows, announced the establishment o...

April 25, 2025 | Friday | News
Atelerix Partners with MineBio to Launch Cryo-Free Cell Preservation Technology in China

Partnership with specialist life science distributor establishes sales channel in high-demand market and strengthens global network Hypothermic pres...

April 16, 2025 | Wednesday | News
Vantage Biosciences Doses First Patient in Phase 2 Trial of VX-01 for Diabetic Retinopathy

Vantage Biosciences is a clinical-stage biotechnology company developing innovative therapies for the treatment of diabetic eye diseases. The company ...

April 14, 2025 | Monday | News
AstraZeneca’s Calquence® Combination Therapy Recommended for EU Approval in Untreated Mantle Cell Lymphoma

AstraZeneca’s Calquence (acalabrutinib) in combination with bendamustine and rituximab has been recommended for approval in the European Un...

March 31, 2025 | Monday | News
GSK Wins FDA Approval for Blujepa, First New Oral Antibiotic for UTIs in Nearly 30 Years

GSK plc announced that the US Food and Drug Administration (FDA) has approved Blujepa (gepotidacin) for the treatment of female adults (≥40 kg...

March 26, 2025 | Wednesday | News
Johnson & Johnson’s TREMFYA® Approved by FDA as First Dual-Acting IL-23 Inhibitor for Crohn’s Disease

Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has approved TREMFYA® (guselkumab), the first and only IL-23...

March 24, 2025 | Monday | News
Telix Pharmaceuticals' Illuccix® Receives Full ANVISA Approval for Prostate Cancer Imaging in Brazil

Telix Pharmaceuticals Limited announces that the Brazilian Health Regulatory Agency (Agencia Nacional de Vigilancia Sanitaria or 'ANVISA') has approve...

March 19, 2025 | Wednesday | News
Zynext Ventures Invests in Illexcor Therapeutics to Advance Next-Generation Oral Treatment for Sickle Cell Disease

 Zynext Ventures USA LLC (Zynext Ventures), the venture capital arm of Zydus Lifesciences (Zydus), announced its investment in Illexcor Ther...

March 13, 2025 | Thursday | News
Octapharma Marks Historic Milestone as NHS Patients Receive UK-Donated Plasma Medicines for the First Time in 30 Years

Octapharma celebrates a historic milestone as NHS patients begin receiving medicines made from UK-donated plasma for the first time in nearly three decad...

March 07, 2025 | Friday | News
Nona Biosciences Unveils AI-Assisted Hu-mAtrIx™ Platform to Revolutionize Antibody Discovery

Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM),  announced to unveil its innovative AI-...

March 07, 2025 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close